Uptake of radiolabeled somatostatin analog is detectable in patients with metastatic foci of sarcoma Academic Article uri icon

Overview

MeSH Major

  • Continuity of Patient Care
  • Patient Care Bundles
  • Patient Discharge

abstract

  • Seventy-one percent of patients with advanced soft-tissue sarcomas had positive scintigraphy scans demonstrating tumor expression of somatostatin receptors subtype 2 in vivo. Imaging with indium-111 pentetreotide could be studied as an adjunct to conventional imaging modalities for assessment of sarcoma patients. Further research is needed to determine the prognostic implications of somatostatin receptor subtype 2 positivity, including larger studies to evaluate any potential correlation with metastatic behavior and other clinical outcomes.

publication date

  • October 15, 1999

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1002/(SICI)1097-0142(19991015)86:8<1621::AID-CNCR33>3.0.CO;2-M

Additional Document Info

start page

  • 1621

end page

  • 7

volume

  • 86

number

  • 8